Delivery Order 36C25625D0004-36C25625N0187

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $351K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Biloxi, MS 39531, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide pharmacy compounding services primarily to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a total ceiling value of $1,610,040.41 and a period of performance ending on May 31, 2025. It was awarded on June 1, 2020 as a Delivery Order under a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA)...
This federal contract award is for the delivery of hazardous sterile compound pharmaceutical services, specifically for the Department of Veterans Affairs (VA) healthcare system. The contract, valued at $100,000.00, was awarded to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is a delivery order under a Firm Fixed Price (FFP) arrangement, with a period of performance through September 30, 2025. The contract...
This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, is for PHARMACY COMPOUNDING services valued at $1,105,798.44. The contract supports the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is a Delivery Order under a Firm Fixed Price contract type. Avella, a 503A certified pharmacy, will provide specialized pharmaceutical compounding services, including chemotherapy...
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $497,705.58 contract is for "CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO" and has an ultimate completion date of September 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Vehicle (IDV) and has a Firm Fixed Price pricing type. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy,...
This federal contract award, with an ID of 36C26025D0038|36C26025N0392, is for the "Contingency Outsourcing of Compounded Chemotherapy Medications" and was issued by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract, which is a delivery order with a firm fixed price, has a ceiling value of $500,000.00 and a period of performance ending on June 29, 2026. The contract is not set-aside and was awarded on June...
This federal contract award is for HAZARDOUS PHARMACY COMPOUNDING SERVICES - OPTION YEAR ONE, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy. The contract has a ceiling value of $650,000.00 and is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. The contract is not associated with any set-aside designation. Optum Pharmacy 801, Inc. is a...
This is a $458,800.00 firm fixed-price purchase order contract awarded to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, by the Department of Veterans Affairs' Veterans Integrated Service Network 2. The contract is for the provision of short-term chemotherapy and other specialized pharmaceutical compounding services to support the VA's oncology and infusion treatment programs. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, is a 503A certified...
This federal contract award, valued at $230,297.50, was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the delivery of sterile compound supply services to support VA oncology and infusion treatment programs nationwide. As the prime contractor, Avella Specialty Pharmacy will compound customized chemotherapy and other...
This federal contract award is for 503A pharmaceutical drug compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. The award has a ceiling value of $119,448.79 and is a delivery order contract with a firm fixed price pricing type. The ultimate completion date for the contract is August 24, 2024. The contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service...
This federal contract award is for HAZARDOUS PHARMACY COMPOUNDING SERVICES to support the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) oncology and infusion treatment programs. The prime contractor is Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $325,000.00, is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type and a performance period through...
  • 36C25625D0004
    Indefinite Delivery Contract
  • 36C25625D0004-36C25625N0187
    Delivery Order

This federal contract award is for hazardous pharmaceutical compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $350,610.57, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16) on a firm fixed-price basis with a completion date of September 30, 2025. Optum Pharmacy 801, Inc. has a history of securing multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with the VA, ranging from $500,000 to $8 million, to provide specialized pharmaceutical compounding services across various VA healthcare networks. This contract award does not have a set-aside designation, indicating that Optum Pharmacy 801, Inc. successfully competed in a full and open commercial competition.

Generated 8/6/25, 9:52 AM